Analyst Consensus ?
ConsensusHold35 ratings
Bullish1234.3%
Neutral1851.4%
Bearish514.3%
FN2 Earnings Intelligence
Dow Inc. (DOW) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Jul 24, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 24, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 20, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 6, 2026 |
| Alembic Global | Overweight | Overweight | Maintain | Jul 2, 2026 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Jul 1, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Jul 1, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Jun 30, 2026 |
| Citigroup | Buy | Buy | Maintain | Jun 24, 2026 |
| Argus Research | Buy | Hold | Upgrade | May 13, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Mar 30, 2026 |
| Jefferies | Hold | Hold | Maintain | Mar 10, 2026 |
| Fermium Research | Buy | Hold | Upgrade | Mar 9, 2026 |
| Keybanc | Overweight | Sector Weight | Upgrade | Mar 4, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 29, 2025 |
| Evercore ISI Group | In Line | Outperform | Downgrade | Jul 25, 2025 |
| Barclays | Equal Weight | Equal Weight | Maintain | Apr 24, 2025 |
| Piper Sandler | Neutral | Neutral | Maintain | Apr 7, 2025 |
| Deutsche Bank | Hold | Hold | Maintain | Sep 12, 2024 |
| Credit Suisse | Underperform | Neutral | Downgrade | Jun 22, 2022 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Apr 19, 2022 |
| Bernstein | Market Perform | Outperform | Downgrade | Nov 13, 2020 |
| Truist Securities | Buy | Buy | Maintain | Sep 21, 2020 |
| HSBC | Reduce | Hold | Downgrade | Sep 16, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 28, 2020 |
| ScotiaBank | Sector Perform | Sector Perform | Maintain | Jul 24, 2020 |
| Nomura | Buy | Buy | Maintain | Sep 18, 2019 |
| Bank of America | Underperform | Neutral | Downgrade | Aug 16, 2019 |
| Susquehanna | Neutral | Positive | Downgrade | Jul 29, 2019 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| CLSA | Underperform | Outperform | Downgrade | Jul 6, 2016 |
| Macquarie | Outperform | Outperform | Maintain | Jun 22, 2015 |
| Gilford Securities | Neutral | Sell | Upgrade | Jan 28, 2015 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Nov 28, 2014 |
| The Oxen Group | Hold | Hold | Maintain | Apr 4, 2012 |
Upside is calculated against the persisted current price $30.09. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $32 | $29.36 | +6.3% | Jul 24, 2026 |
| Morgan Stanley | Analyst unavailable | $39 | $30.04 | +29.6% | Jul 20, 2026 |
| Goldman Sachs | Duffy Fischer | $34 | $29.68 | +13.0% | Jul 16, 2026 |
| BMO Capital | Analyst unavailable | $33 | $27.71 | +9.7% | Jul 6, 2026 |
| Wells Fargo | Analyst unavailable | $35 | $27.71 | +16.3% | Jul 3, 2026 |
| Alembic Global | Hassan Ahmed | $45 | $27.02 | +49.6% | Jul 2, 2026 |
| Mizuho Securities | John Roberts | $35 | $27.36 | +16.3% | Jul 1, 2026 |
| RBC Capital | Analyst unavailable | $28 | $27.36 | -6.9% | Jul 1, 2026 |
| UBS | Analyst unavailable | $37 | $34.14 | +23.0% | Jun 5, 2026 |
| Deutsche Bank | Analyst unavailable | $40 | $38.24 | +32.9% | Apr 27, 2026 |
| RBC Capital | Arun Viswanathan | $51 | $38.66 | +69.5% | Apr 27, 2026 |
| UBS | Analyst unavailable | $39 | $39.02 | +29.6% | Apr 24, 2026 |
| BMO Capital | Analyst unavailable | $46 | $38.22 | +52.9% | Apr 24, 2026 |
| Morgan Stanley | Analyst unavailable | $41 | $37.16 | +36.3% | Apr 21, 2026 |
| RBC Capital | Arun Viswanathan | $47 | $38.8 | +56.2% | Apr 10, 2026 |
| Alembic Global | Hassan Ahmed | $50 | $38.04 | +66.2% | Apr 9, 2026 |
| UBS | Analyst unavailable | $40 | $39.47 | +32.9% | Mar 26, 2026 |
| Fermium Research | Frank Mitsch | $38 | $34.31 | +26.3% | Mar 9, 2026 |
| Vertical Research | Analyst unavailable | $37 | $34.31 | +23.0% | Mar 9, 2026 |
| RBC Capital | Analyst unavailable | $40 | $34.31 | +32.9% | Mar 9, 2026 |
| KeyBanc | Aleksey Yefremov | $38 | $30.74 | +26.3% | Mar 4, 2026 |
| UBS | Joshua Spector | $28 | $27.56 | -6.9% | Jan 30, 2026 |
| Jefferies | Laurence Alexander | $28 | $27.16 | -6.9% | Jan 30, 2026 |
| RBC Capital | Analyst unavailable | $29 | $27.66 | -3.6% | Jan 16, 2026 |
| Mizuho Securities | John Roberts | $27 | $24.8 | -10.3% | Jan 8, 2026 |
| UBS | Analyst unavailable | $23 | $23.42 | -23.6% | Dec 23, 2025 |
| Deutsche Bank | David Begleiter | $25 | $22.98 | -16.9% | Dec 18, 2025 |
| Goldman Sachs | Analyst unavailable | $27 | $25.31 | -10.3% | Oct 29, 2025 |
| RBC Capital | Arun Viswanathan | $27 | $24.51 | -10.3% | Oct 24, 2025 |
| UBS | Joshua Spector | $25 | $24.51 | -16.9% | Oct 24, 2025 |
| Mizuho Securities | John Roberts | $25 | $24.51 | -16.9% | Oct 24, 2025 |
| Goldman Sachs | Analyst unavailable | $24 | $21.9 | -20.2% | Oct 17, 2025 |
| RBC Capital | Arun Viswanathan | $24 | $21.64 | -20.2% | Oct 14, 2025 |
| UBS | Analyst unavailable | $24 | $23.54 | -20.2% | Oct 6, 2025 |
| Mizuho Securities | Analyst unavailable | $26 | $23.69 | -13.6% | Oct 3, 2025 |
| Wells Fargo | Analyst unavailable | $30 | $24.14 | -0.3% | Sep 9, 2025 |
| Redburn Partners | Colin Isaac | $40 | $22.38 | +32.9% | Aug 5, 2025 |
| BMO Capital | John McNulty | $20 | $25.18 | -33.5% | Jul 29, 2025 |
| BMO Capital | Analyst unavailable | $22 | $26.87 | -26.9% | Jun 23, 2025 |
| RBC Capital | Arun Viswanathan | $30 | $30.02 | -0.3% | Apr 25, 2025 |
| Barclays | Michael Leithead | $32 | $29.76 | +6.3% | Apr 24, 2025 |
| Wells Fargo | Michael Sison | $40 | $28.2 | +32.9% | Apr 4, 2025 |
| RBC Capital | Arun Viswanathan | $44 | $40 | +46.2% | Dec 19, 2024 |
| Evercore ISI | Eric Boyes | $56 | $40.57 | +86.1% | Dec 17, 2024 |
| Wells Fargo | Michael Sison | $55 | $42.18 | +82.8% | Dec 10, 2024 |
| Piper Sandler | Charles Neivert | $60 | $46.49 | +99.4% | Nov 8, 2024 |
| Citigroup | Pat Cunningham | $52 | $50.15 | +72.8% | Sep 13, 2024 |
| RBC Capital | Arun Viswanathan | $55 | $50.26 | +82.8% | Sep 13, 2024 |
| Deutsche Bank | David Begleiter | $53 | $50.04 | +76.1% | Sep 12, 2024 |
| BMO Capital | John McNulty | $57 | $52.98 | +89.4% | Jul 26, 2024 |
| Piper Sandler | Charles Neivert | $64 | $53.06 | +112.7% | Jul 26, 2024 |
| RBC Capital | Arun Viswanathan | $57 | $53.06 | +89.4% | Jul 26, 2024 |
| Jefferies | Laurence Alexander | $55 | $55.44 | +82.8% | Jun 20, 2024 |
| Evercore ISI | Stephen Richardson | $62 | $58.7 | +106.0% | May 17, 2024 |
| UBS | John Roberts | $61 | $58.7 | +102.7% | May 16, 2024 |
| Piper Sandler | Charles Neivert | $68 | $57.61 | +126.0% | Apr 29, 2024 |
| Wells Fargo | Michael Sison | $68 | $58.26 | +126.0% | Apr 2, 2024 |
| J.P. Morgan | Jeffrey Zekauskas | $55 | $50.27 | +82.8% | Oct 17, 2023 |
| Morgan Stanley | Vincent Andrews | $54 | $55.62 | +79.5% | Jul 31, 2023 |
| Deutsche Bank | David Begleiter | $60 | $51.8 | +99.4% | Jun 13, 2023 |
| UBS | Analyst unavailable | $57 | $57.3 | +89.4% | Jan 11, 2023 |
| Wells Fargo | Analyst unavailable | $60 | $55.97 | +99.4% | Jan 9, 2023 |
| Citigroup | Analyst unavailable | $56 | $51.36 | +86.1% | Dec 15, 2022 |
| Fermium Research | Frank Mitsch | $50 | $45.77 | +66.2% | Oct 21, 2022 |
| Fermium Research | Analyst unavailable | $60 | $50.51 | +99.4% | Sep 9, 2022 |
| Mizuho Securities | Christopher Parkinson | $62 | $52.55 | +106.0% | Aug 2, 2022 |
| Morgan Stanley | Analyst unavailable | $60 | $51.58 | +99.4% | Jul 26, 2022 |
| Barclays | Analyst unavailable | $60 | $50.96 | +99.4% | Jul 11, 2022 |
| Credit Suisse | John Roberts | $49 | $51.8 | +62.8% | Jun 22, 2022 |
| Jefferies | Laurence Alexander | $81 | $54.77 | +169.2% | Jun 20, 2022 |
| Jefferies | Analyst unavailable | $74 | $55.58 | +145.9% | Jun 16, 2022 |
| Evercore ISI | Stephen Richardson | $68 | $69.06 | +126.0% | May 31, 2022 |
| Piper Sandler | Charles Neivert | $78 | $67.49 | +159.2% | May 24, 2022 |
| Barclays | Michael Leithead | $72 | $66.5 | +139.3% | May 2, 2022 |
| Argus Research | Bill Selesky | $81 | $67.81 | +169.2% | Apr 28, 2022 |
| Morgan Stanley | Analyst unavailable | $76 | $66.17 | +152.6% | Apr 25, 2022 |
| Deutsche Bank | David Begleiter | $74 | $69.51 | +145.9% | Apr 22, 2022 |
| J.P. Morgan | Analyst unavailable | $80 | $68.5 | +165.9% | Apr 22, 2022 |
| Wells Fargo | Analyst unavailable | $80 | $70.64 | +165.9% | Apr 22, 2022 |
| BMO Capital | Analyst unavailable | $76 | $69.51 | +152.6% | Apr 22, 2022 |
| RBC Capital | Analyst unavailable | $70 | $69.51 | +132.6% | Apr 22, 2022 |
| Citigroup | Analyst unavailable | $82 | $69.51 | +172.5% | Apr 22, 2022 |
| Mizuho Securities | Chris Parkinson | $68 | $69.51 | +126.0% | Apr 21, 2022 |
| Fermium Research | Frank Mitsch | $80 | $69.51 | +165.9% | Apr 21, 2022 |
| RBC Capital | Arun Viswanathan | $70 | $69.51 | +132.6% | Apr 21, 2022 |
| Wolfe Research | Analyst unavailable | $64 | $67.2 | +112.7% | Apr 19, 2022 |
| Mizuho Securities | Christopher Parkinson | $68 | $65.88 | +126.0% | Apr 19, 2022 |
| Deutsche Bank | David Begleiter | $66 | $63.34 | +119.3% | Mar 21, 2022 |
| Wells Fargo | Michael Sison | $72 | $59.46 | +139.3% | Jan 27, 2022 |
| Mizuho Securities | Chris Parkinson | $65 | $58.55 | +116.0% | Jan 12, 2022 |
| Citigroup | PJ Juvekar | $63 | $58.47 | +109.4% | Jan 11, 2022 |
| Barclays | Duffy Fischer | $69 | $57 | +129.3% | Oct 22, 2021 |
| Wolfe Research | Josh Silverstein | $55 | $57.54 | +82.8% | Oct 18, 2021 |
| HSBC | Sriharsha Pappu | $52 | $60.98 | +72.8% | Jun 23, 2021 |
| Argus Research | Bill Selesky | $78 | $66.99 | +159.2% | Jun 8, 2021 |
Track every rating change on DOW the moment it posts. Free to start.
Start free